Fondaparinux plus vitamin K antagonist vs usual care
All harmful effects · people > 18 years of age with a diagnosed deep vein thrombosis
It is very uncertain whether fondaparinux plus vitamin K antagonist changes all harmful effects compared with standard therapy (very low certainty).
1 finding from 1 review
- RR 0.84 [0.76, 0.93]1 study · 2192 participantsVery low